Categories Health Care

Soliton spikes over 50% on its decision to proceed with cellulite trials

Shares of Soliton Inc. (NASDAQ: SOLY) jumped over 50% during the morning trade on Wednesday after the medical device company said in a statement that it would move forward with the pivotal trial of its Rapid Acoustic Pulse (RAP) device for the treatment of cellulite.

The Houston-based firm said the decision was based on the positive data from its proof of concept (POC) clinical trial. In the POC trial, the range of improvement in cellulite severity score was 20% to 47% and the average improvement for all patients was nearly a 30% improvement, the company said.

soliton tattoo removal device FDA
Image for representation. Photo by Allef Vinicius on Unsplash

The pivotal trial is expected to begin within three months. The RAP device had earlier received clearance from the US Food and Drug Administration (FDA) for the purpose of tattoo removal, according to Soliton.

READ: WHAT IS NASH AND WHICH BIOTECH FIRMS ARE VYING FOR THE FIRST-MOVER STATUS

“The market for non-invasive cellulite treatments is about $1 billion in the US, so it is clear that many women who are affected by the condition are interested in finding ways to reduce or eliminate it,” said co-founder Walter Klemp.

In February this year, the company had a Regulation A+ IPO, meaning it raised money from public funding. SOLY shares have almost tripled since then, despite criticisms that the company is driving the stock with regular meaningless updates.

Browse through our earnings calendar and get all scheduled earnings announcements, analyst/investor conference and much more!

Most Popular

Does Unity Software (U) stock has more room to run?

Last month, the IPO market was in a full swing. IPOs of Snowflake (NYSE: SNOW) and JFROG (NASDAQ: FROG) had an impressive opening day in September, the former creating a

PepsiCo (PEP): Steady snacking habits amid pandemic drive strong quarter for beverage giant

PepsiCo Inc. (NASDAQ: PEP) beat market expectations on both revenue and earnings for the third quarter of 2020. The company saw the momentum continue in its snacks business while the

Does the virus-driven boom make Electronic Arts (EA) a good investment?

With more and more people turning to virtual entertainment sources, amid the virus-related movement restrictions, video game publishers like Electronic Arts (NASDAQ: EA) are witnessing unusually high demand. Not surprisingly,

Leave a Reply

Your email address will not be published. Required fields are marked *

Add Comment
Loading...

Cancel
Viewing Highlight
Loading...
Highlight
Close
Top